SCHEMBL7206870

SCHEMBL7206870

CC(C)c1[c]c(C(C)C)cc(C(=O)COc2c(C(C)C)cc(C(C)C)cc2C(C)C)c1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 1/20 0.39
FABP3 P05413 2/20 0.38
FABP4 P15090 2/20 0.38
GLRA1 P23415 1/20 0.36
RXRA P19793 9/20 0.35
PPARG P37231 7/20 0.35
RARG P13631 6/20 0.35
FABP5 Q01469 1/20 0.34
HMGCR P04035 1/20 0.33
SOAT2 O75908 1/20 0.33
MYC P01106 1/20 0.33
SOAT1 P35610 1/20 0.33
MAP2K3 P46734 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRB2 P47870 1/20 0.33
RARA P10276 1/20 0.32
RARB P10826 1/20 0.32
RXRB P28702 1/20 0.32
RXRG P48443 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7206959 0.86 GLRA1 (0.39) SRD5A2GLRA1SOAT2MYCSOAT1
SCHEMBL7206928 0.78 FABP3 (0.41) FABP3FABP4FABP5SOAT2MYC
SCHEMBL7206867 0.78 SRD5A2 (0.38) SRD5A2FABP3FABP4GLRA1RXRA
SCHEMBL7109323 0.76 FABP3 (0.39) FABP3FABP4FABP5SOAT2MYC
SCHEMBL8498111 0.76 FABP3 (0.52) SRD5A2FABP3FABP4GLRA1RXRA
SCHEMBL7108814 0.70 FABP3 (0.41) FABP3FABP4FABP5GABRA1GABRB2
SCHEMBL8706010 0.69 FABP3 (0.38) FABP3FABP4FABP5SOAT2MYC
SCHEMBL2361439 0.69 GSK3B (0.42)
SCHEMBL7104863 0.69 FABP3 (0.40) FABP3FABP4FABP5GABRA1GABRB2
SCHEMBL7105200 0.68 FABP3 (0.39) FABP3FABP4RXRAPPARGRARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0841913-B1 USE OF SULFAMIC ACID DERIVATIVES, ACYL SULFONAMIDES OR SULFONYL CARBAMATES FOR THE MANUFACTURE OF A MEDICAMENT FOR LOWERING LIPOPROTEIN LEVELS WARNER LAMBERT CO (US) 2003-02-05 EP claimed